Shinva Water Bath Sterilizer Obtains EAC Certification for EAEU Market
On July 9, 2026, the core product – water bath sterilizer developed by Shinva Pharmaceutical Technology Group officially received the EAC certification certificate. This marks the first time Shinva’s water bath sterilizer has secured market access qualification for the Eurasian Economic Union (EAEU). It verifies that the product’s design, manufacturing and full quality control system fully comply with mandatory safety standards of the five EAEU member states, granting Shinva a critical permit to further explore the Eurasian market.
EAC Certification: A Unified Passport Across Five EAEU Nations
EAC certification is the sole mandatory market access credential valid throughout the five EAEU member countries: Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan. Replacing the former Russian GOST-R certification system, it enables one single certification, free circulation across all five member states.
Per EAEU technical regulations, water bath sterilizers fall under pressure equipment. Mandatory EAC conformity certification in accordance with TR CU 032/2013 Technical Regulation on the Safety of Pressure Equipment is a legal prerequisite before any product can be marketed and operated within the union’s territory.
Recognized Globally by Cutting-edge Technology & Comprehensive Manufacturing Capacity
The EAC certification audit adopted extremely rigorous assessment criteria, thoroughly inspecting Shinva’s full industrial chain capabilities spanning product design, production and quality management.
Aligned with TR CU 032/2013 requirements, certification authorities conducted exhaustive reviews of core welding procedures during manufacturing audits. Furthermore, the company’s ISO 9001:2015 quality management system certificate (Registration No. CN20/10802.00) provided robust systematic support for the successful certification, demonstrating standardized and streamlined operational management.
Expanding Global Certification Portfolio, Another Milestone for Shinva’s Internationalization Strategy
2026 kicks off Shinva’s 15th Five-Year Development Plan, with deepened international expansion listed as one of the company’s three core strategic priorities.
This newly awarded EAC certification follows a string of prestigious global accreditations including EU CE-MDR, North American UL and EU EN13445, representing another landmark breakthrough in Shinva’s layout of high-end international medical equipment markets.
To date, Shinva Pharmaceutical Technology Group has built a comprehensive certification portfolio covering major global markets including the EU, North America and the EAEU. The diverse array of international qualifications lays a solid foundation for the in-depth advancement of the company’s global internationalization strategy.